Preadmission Insulin-Treated Type 2 Diabetes Mellitus Patients Had Increased Mortality in Intensive Care Units

References

• Zhou B, Lu Y, Hajifathalian K, et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. Lancet. 2016;387(10027):1513–1530.
   PubMed Web of Science ®Google Scholar
• Krug EG. Trends in diabetes: sounding the alarm. Lancet. 2016;387(10027):1485–1486. doi:10.1016/S0140-6736(16)30163-5
   PubMed Web of Science ®Google Scholar
• Siegelaar SE, Hickmann M, Hoekstra JB, Holleman F, DeVries JH. The effect of diabetes on mortality in critically ill patients: a systematic review and meta-analysis. Crit Care. 2011;15(5):R205. doi:10.1186/cc10440
   Web of Science ®Google Scholar
• Christiansen CF, Johansen MB, Christensen S, O’Brien JM, Tonnesen E, Sorensen HT. Type 2 diabetes and 1-year mortality in intensive care unit patients. Eur J Clin Invest. 2013;43(3):238–247. doi:10.1111/eci.12036
   PubMed Web of Science ®Google Scholar
• Chase JG, Desaive T, Bohe J, et al. Improving glycemic control in critically ill patients: personalized care to mimic the endocrine pancreas. Crit Care. 2018;22(1):182. doi:10.1186/s13054-018-2110-1
   Web of Science ®Google Scholar
• Preiser JC, van Zanten AR, Berger MM, et al. Metabolic and nutritional support of critically ill patients: consensus and controversies. Crit Care. 2015;19:35. doi:10.1186/s13054-015-0737-8
   PubMed Web of Science ®Google Scholar
• McDonnell ME, Umpierrez GE. Insulin therapy for the management of hyperglycemia in hospitalized patients. Endocrinol Metab Clin North Am. 2012;41(1):175–201. doi:10.1016/j.ecl.2012.01.001
   Web of Science ®Google Scholar
• Rachdaoui N. Insulin: the friend and the foe in the development of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(5):1770. doi:10.3390/ijms21051770
   PubMed Web of Science ®Google Scholar
• Fonseca VA, Haggar MA. Achieving glycaemic targets with basal insulin in T2DM by individualizing treatment. Nat Rev Endocrinol. 2014;10(5):276–281. doi:10.1038/nrendo.2014.17
   Web of Science ®Google Scholar
• Weng J, Li Y, Xu W, et al. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet. 2008;371(9626):1753–1760. doi:10.1016/S0140-6736(08)60762-X
   PubMed Web of Science ®Google Scholar
• Weng J. Short-term intensive insulin therapy could be the preferred option for new onset type 2 diabetes mellitus patients with HbA1c > 9. J Diabetes. 2017;9(10):890–893. doi:10.1111/1753-0407.12581
   Web of Science ®Google Scholar
• Hanefeld M, Bramlage P. Insulin use early in the course of type 2 diabetes mellitus: the ORIGIN trial. Curr Diab Rep. 2013;13(3):342–349. doi:10.1007/s11892-013-0366-z
   Web of Science ®Google Scholar
• van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359–1367. doi:10.1056/NEJMoa011300
   PubMed Web of Science ®Google Scholar
• Pittas AG, Siegel RD, Lau J. Insulin therapy and in-hospital mortality in critically ill patients: systematic review and meta-analysis of randomized controlled trials. JPEN J Parenter Enteral Nutr. 2006;30(2):164–172. doi:10.1177/0148607106030002164
   Web of Science ®Google Scholar
• van Steen SC, Rijkenberg S, van der Voort PHJ, DeVries JH. The association of intravenous insulin and glucose infusion with intensive care unit and hospital mortality: a retrospective study. Ann Intensive Care. 2019;9(1):29. doi:10.1186/s13613-019-0507-x
   Web of Science ®Google Scholar
• Yu B, Li C, Sun Y, Wang DW. Insulin treatment is associated with increased mortality in patients with COVID-19 and type 2 diabetes. Cell Metab. 2021;33(1):65–77 e2. doi:10.1016/j.cmet.2020.11.014
   PubMed Web of Science ®Google Scholar
• Gamble JM, Simpson SH, Eurich DT, Majumdar SR, Johnson JA. Insulin use and increased risk of mortality in type 2 diabetes: a cohort study. Diabetes Obes Metab. 2010;12(1):47–53. doi:10.1111/j.1463-1326.2009.01125.x
   PubMed Web of Science ®Google Scholar
• China Diabetes Society. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition) (in Chinese). Chin J Endocrinol Metabol. 2021;13(4):315–409.
   Google Scholar
• Bolliger D, Seeberger MD, Lurati Buse G, et al. The influence of pre-admission hypoglycaemic therapy on cardiac morbidity and mortality in type 2 diabetic patients undergoing major non-cardiac surgery: a prospective observational study. Anaesthesia. 2012;67(2):149–157. doi:10.1111/j.1365-2044.2011.06963.x
   Web of Science ®Google Scholar
• Haltmeier T, Benjamin E, Beale E, Inaba K, Demetriades D. Insulin-treated patients with diabetes mellitus undergoing emergency abdominal surgery have worse outcomes than patients treated with oral agents. World J Surg. 2016;40(7):1575–1582. doi:10.1007/s00268-016-3469-2
   Web of Science ®Google Scholar
• Reinstadler SJ, Stiermaier T, Eitel C, et al. Relationship between diabetes and ischaemic injury among patients with revascularized ST-elevation myocardial infarction. Diabetes Obes Metab. 2017;19(12):1706–1713. doi:10.1111/dom.13002
   Web of Science ®Google Scholar
• Xiu F, Stanojcic M, Diao L, Jeschke MG. Stress hyperglycemia, insulin treatment, and innate immune cells. Int J Endocrinol. 2014;2014:486403. doi:10.1155/2014/486403
   PubMed Web of Science ®Google Scholar
• Li L, Messina JL. Acute insulin resistance following injury. Trends Endocrinol Metab. 2009;20(9):429–435. doi:10.1016/j.tem.2009.06.004
   PubMed Web of Science ®Google Scholar
• Kodner C, Anderson L, Pohlgeers K. Glucose management in hospitalized patients. Am Fam Physician. 2017;96(10):648–654.
   Web of Science ®Google Scholar
• Nuzzo A, Brignoli A, Ponziani M, et al. Aging and comorbidities influence the risk of hospitalization and mortality in diabetic patients experiencing severe hypoglycemia. Nutr Metab Cardiovasc Dis. 2022;32(1):160–166. doi:10.1016/j.numecd.2021.09.016
   Web of Science ®Google Scholar
• McCoy RG, Lipska KJ, Yao X, Ross JS, Montori VM, Shah ND. Intensive treatment and severe hypoglycemia among adults with type 2 diabetes. JAMA Intern Med. 2016;176(7):969–978. doi:10.1001/jamainternmed.2016.2275
   Web of Science ®Google Scholar
• Standl E, Stevens SR, Lokhnygina Y, et al. Confirming the bidirectional nature of the association between severe hypoglycemic and cardiovascular events in type 2 diabetes: insights from EX SCEL. Diabetes Care. 2020;43(3):643–652. doi:10.2337/dc19-1079
   Web of Science ®Google Scholar
• Kolb H, Kempf K, Rohling M, Martin S. Insulin: too much of a good thing is bad. BMC Med. 2020;18(1):224. doi:10.1186/s12916-020-01688-6
   PubMed Web of Science ®Google Scholar
• Brundage SI, Kirilcuk NN, Lam JC, Spain DA, Zautke NA. Insulin increases the release of proinflammatory mediators. J Trauma. 2008;65(2):367–372. doi:10.1097/TA.0b013e3181801cc0
   Google Scholar
• Filgueiras LR, Capelozzi VL, Martins JO, Jancar S. Sepsis-induced lung inflammation is modulated by insulin. BMC Pulm Med. 2014;14:177. doi:10.1186/1471-2466-14-177
   Web of Science ®Google Scholar
• Ieronymaki E, Daskalaki MG, Lyroni K, Tsatsanis C. Insulin signaling and insulin resistance facilitate trained immunity in macrophages through metabolic and epigenetic changes. Front Immunol. 2019;10:1330. doi:10.3389/fimmu.2019.01330
   PubMed Web of Science ®Google Scholar
• Preiser JC, Ichai C, Orban JC, Groeneveld AB. Metabolic response to the stress of critical illness. Br J Anaesth. 2014;113(6):945–954. doi:10.1093/bja/aeu187
   Web of Science ®Google Scholar
• Schwartz GG, Nicholls SJ, Toth PP, et al. Relation of insulin treatment for type 2 diabetes to the risk of major adverse cardiovascular events after acute coronary syndrome: an analysis of the BETonMACE randomized clinical trial. Cardiovasc Diabetol. 2021;20(1):125. doi:10.1186/s12933-021-01311-9
   Web of Science ®Google Scholar
• Iliadis F, Kadoglou N, Didangelos T. Insulin and the heart. Diabetes Res Clin Pract. 2011;93(Suppl 1):S86–S91. doi:10.1016/S0168-8227(11)70019-5
   Web of Science ®Google Scholar
• Bondy SC, Wu M, Prasad KN. Alternatives to insulin for the regulation of blood sugar levels in type 2 diabetes. Int J Mol Sci. 2020;21(21):8302. doi:10.3390/ijms21218302
   Web of Science ®Google Scholar
• Vijan S, Sussman JB, Yudkin JS, Hayward RA. Effect of patients’ risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus. JAMA Intern Med. 2014;174(8):1227–1234. doi:10.1001/jamainternmed.2014.2894
   Web of Science ®Google Scholar